Scroll Back to Top

Kazuya Iwamoto, MD, PhD, FACP

Senior Medical Director

Connect with me

Kazuya Iwamoto, MD, PhD, MBA, FACP, is Senior Medical Director for Fortrea in Osaka, Japan. He provides medical and scientific expertise to oncology study teams on clients’ drug development projects and contributes to the development of medical strategies and execution of clinical trials. Dr. Iwamoto has more than 25 years of experience as a physician, research clinician and medical director. 

Before joining Fortrea, he was Head of the Medical Division, including Clinical Development and Medical Affairs, for Hospira Japan in Osaka. He previously served as Head of the Medical Division for Biogen Idec, Head of Medical Affairs for Bayer Yakuhin, and Clinical Research Physician for Eli Lilly in Japan. Currently President and Fellow of the Japanese Association of Pharmaceutical Medicine, Dr. Iwamoto joined our company in May 2016.

Publications

Choose how you like to connect.

We've been driving innovation with our tailored clinical solutions for 30+ years. Let's connect.

Write to us
Book a Meeting

Prefer to send an inquiry?

Tell us about your needs and our team will follow up shortly.

Service Interest(s)
(Word, PDF, PPT, Excel, Image)
One file only.
60 MB limit.
Allowed types: gif, jpg, jpeg, png, bmp, txt, rtf, html, pdf, doc, docx, ppt, pptx, xls, xlsx, xml.
Name

I agree to be contacted about products and services and receive other communications from Fortrea Inc. Please review Fortrea's Privacy Policy for further information. By submitting below, you consent to allow Fortrea Inc to store and process the personal information submitted above to provide you the content requested.

By clicking submit below, you consent to allow Fortrea Inc to store and process the personal information submitted above to provide you the content requested.

Need to speak directly with our sales team?

Connect with our sales team to discuss your needs and explore the right solutions for your clinical development goals — quick, clear, and hassle‑free.